Majority of U.S. Teens Underestimate Lethal Risk of Fentanyl, Study Finds

More than half of American 8th-graders and roughly one-third of high school students do not perceive significant danger from using fentanyl even once or twice, according to research published July 7 in JAMA Network Open. The findings from the 2025 Monitoring the Future survey reveal troubling knowledge gaps about a synthetic opioid that now contributes to at least three-quarters of adolescent overdose deaths nationwide.

The study, led by researchers at the University of Michigan's Institute for Social Research, marks the first time the long-running national survey has specifically asked adolescents about their perception of fentanyl risk. Among nearly 4,000 student respondents, only 48 percent of 8th-graders, 64 percent of 10th-graders, and 70 percent of 12th-graders classified one-time or experimental fentanyl use as carrying "great risk."

A Misunderstood Threat

Fentanyl's lethality bears no relationship to the dose-response patterns adolescents may associate with other substances. The synthetic opioid is up to 50 times more potent than heroin, and amounts smaller than a grain of sand can prove fatal—particularly for young people with no opioid tolerance. Yet the survey responses suggest many teenagers apply a familiar framework of escalating risk to a substance where even minimal exposure can be deadly.

"The concept of increasing risk with rising use applies to some substances, such as alcohol, smoking and marijuana, but it's not the right framing for fentanyl, which can be fatal with one exposure," the study authors note. This fundamental misunderstanding may leave adolescents vulnerable to catastrophic outcomes from what they perceive as low-risk experimentation.

Drug poisonings and overdoses now rank as the third leading cause of death for American children and teenagers, trailing only firearms and motor vehicle accidents. While overall adolescent illicit drug use has declined in recent years, overdose fatalities among young people have risen—a divergence driven almost entirely by fentanyl contamination of the drug supply.

The Counterfeit Pill Danger

The most common route of fentanyl exposure for adolescents occurs unintentionally through counterfeit prescription medications. Fake pills designed to resemble oxycodone, Xanax, or Adderall frequently contain lethal doses of fentanyl or are composed entirely of the synthetic opioid. Young people seeking to experiment with prescription stimulants for academic performance or anti-anxiety medications for recreational use may consume fentanyl without any awareness of what they are taking.

The Drug Enforcement Administration has documented thousands of counterfeit pill seizures containing potentially lethal fentanyl doses. Laboratory analysis consistently shows wide variation in potency, with some counterfeit tablets containing more than twice the amount of fentanyl associated with fatal overdoses in opioid-naive individuals.

Between 9 and 17 percent of students across grade levels reported being unfamiliar with fentanyl—awareness levels comparable to their familiarity with heroin. This knowledge gap persists despite years of public health campaigns and media coverage of the fentanyl crisis, suggesting that messaging has not effectively reached adolescent populations.

Implications for Prevention

The study findings carry significant implications for school-based drug education and harm reduction strategies. Traditional prevention curricula often emphasize abstinence from all drug use or focus on the developmental risks of substance use during adolescence. While these approaches retain value, they may not adequately address the specific acute dangers posed by fentanyl contamination.

Public health experts increasingly advocate for education that explicitly warns young people about counterfeit pills and the impossibility of identifying fentanyl contamination through visual inspection, taste, or smell. Some jurisdictions have expanded access to fentanyl test strips and naloxone in schools, though these harm reduction tools remain controversial in many educational settings.

The research also highlights the need for developmentally appropriate messaging about overdose response. Adolescents who use drugs with peers may be present during overdose events, and their actions in those critical minutes can determine survival outcomes. Training young people to recognize overdose signs, administer naloxone, and seek emergency assistance could save lives even among populations who never personally use opioids.

Racial and Geographic Disparities

While the JAMA study focused on overall adolescent risk perception, previous research has documented significant disparities in how the fentanyl crisis affects different communities. Black and Latino youth have experienced disproportionate increases in overdose mortality in recent years, even as overall adolescent drug use has remained stable or declined. These disparities likely reflect multiple factors including differential exposure to contaminated drug supplies, barriers to accessing harm reduction services, and variations in the availability of evidence-based treatment.

Rural communities have also faced particular challenges as fentanyl has spread beyond urban centers where the synthetic opioid first dominated illicit markets. Geographic isolation can delay emergency response times during overdose events, compounding the lethality of fentanyl's rapid onset of respiratory depression.

The Broader Context

The adolescent risk perception findings arrive as the United States records sustained declines in overall overdose mortality. National data show overdose deaths have fallen approximately 14 percent from their August 2023 peak, marking the longest sustained decrease in more than four decades. However, these improvements have not been evenly distributed, and young people remain particularly vulnerable to the evolving drug supply.

The Monitoring the Future survey has tracked adolescent substance use patterns since 1975, providing one of the most comprehensive longitudinal datasets on youth behavior in the world. The addition of fentanyl-specific questions reflects recognition that the synthetic opioid crisis requires targeted research and intervention approaches distinct from those developed for earlier waves of substance use.

Moving Forward

Addressing the knowledge gaps documented in the JAMA study will require coordinated efforts across multiple sectors. Schools remain essential venues for reaching adolescents, but effective education must move beyond traditional drug prevention curricula to address the specific realities of the fentanyl era. Healthcare providers who interact with young people—pediatricians, emergency department staff, and mental health professionals—can play crucial roles in delivering targeted risk information during clinical encounters.

Social media platforms, where young people increasingly receive health information, present both challenges and opportunities. While these platforms have been used to market counterfeit pills and connect drug buyers with sellers, they also offer channels for delivering harm reduction messaging in formats that resonate with adolescent audiences.

The study's authors emphasize that improving fentanyl risk perception represents only one component of a comprehensive prevention strategy. Reducing adolescent overdose deaths will ultimately require addressing the broader factors that drive young people to seek psychoactive substances—including untreated mental health conditions, social isolation, and economic precarity—while ensuring that those who develop substance use disorders can access effective, developmentally appropriate treatment.

For now, the research makes clear that many American teenagers are navigating an unprecedented drug supply without adequate understanding of the lethal risks they may encounter. Closing that knowledge gap has become an urgent public health priority as communities work to protect their youngest members from a crisis that has already claimed too many young lives.